JP7050795B2 - ミッドフィールド送信機および受信機システム - Google Patents
ミッドフィールド送信機および受信機システム Download PDFInfo
- Publication number
- JP7050795B2 JP7050795B2 JP2019541245A JP2019541245A JP7050795B2 JP 7050795 B2 JP7050795 B2 JP 7050795B2 JP 2019541245 A JP2019541245 A JP 2019541245A JP 2019541245 A JP2019541245 A JP 2019541245A JP 7050795 B2 JP7050795 B2 JP 7050795B2
- Authority
- JP
- Japan
- Prior art keywords
- implantable
- midfield
- circuit
- circuit board
- housing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004020 conductor Substances 0.000 claims description 96
- 239000000463 material Substances 0.000 claims description 88
- 230000000638 stimulation Effects 0.000 claims description 86
- 238000002513 implantation Methods 0.000 claims description 28
- 229910000679 solder Inorganic materials 0.000 claims description 16
- 238000005219 brazing Methods 0.000 claims description 4
- 238000003466 welding Methods 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 description 147
- 210000001519 tissue Anatomy 0.000 description 90
- 238000000034 method Methods 0.000 description 85
- 239000003989 dielectric material Substances 0.000 description 60
- 230000001537 neural effect Effects 0.000 description 46
- 238000011282 treatment Methods 0.000 description 46
- 210000004204 blood vessel Anatomy 0.000 description 45
- 238000004891 communication Methods 0.000 description 38
- 230000001225 therapeutic effect Effects 0.000 description 36
- 230000004936 stimulating effect Effects 0.000 description 28
- 230000005284 excitation Effects 0.000 description 26
- 238000002560 therapeutic procedure Methods 0.000 description 25
- 230000008901 benefit Effects 0.000 description 23
- 239000007943 implant Substances 0.000 description 23
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 16
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 14
- 238000005516 engineering process Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 13
- 238000003860 storage Methods 0.000 description 13
- 238000012546 transfer Methods 0.000 description 13
- 239000003990 capacitor Substances 0.000 description 12
- 230000008878 coupling Effects 0.000 description 12
- 238000010168 coupling process Methods 0.000 description 12
- 238000005859 coupling reaction Methods 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 12
- 230000005540 biological transmission Effects 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 210000005166 vasculature Anatomy 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 230000009977 dual effect Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 229910052697 platinum Inorganic materials 0.000 description 9
- 210000001367 artery Anatomy 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 7
- 229910010293 ceramic material Inorganic materials 0.000 description 7
- 229910052802 copper Inorganic materials 0.000 description 7
- 239000010949 copper Substances 0.000 description 7
- 238000009434 installation Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 210000001186 vagus nerve Anatomy 0.000 description 7
- 230000002792 vascular Effects 0.000 description 7
- 239000004593 Epoxy Substances 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 6
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 6
- 239000000560 biocompatible material Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 229910052741 iridium Inorganic materials 0.000 description 5
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 208000004296 neuralgia Diseases 0.000 description 5
- 230000010287 polarization Effects 0.000 description 5
- 229920000647 polyepoxide Polymers 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 125000003700 epoxy group Chemical group 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 230000030214 innervation Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000007383 nerve stimulation Effects 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 208000028173 post-traumatic stress disease Diseases 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001913 submandibular gland Anatomy 0.000 description 4
- 210000002972 tibial nerve Anatomy 0.000 description 4
- 210000003901 trigeminal nerve Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 210000001260 vocal cord Anatomy 0.000 description 4
- 239000004606 Fillers/Extenders Substances 0.000 description 3
- 208000003098 Ganglion Cysts Diseases 0.000 description 3
- 206010020853 Hypertonic bladder Diseases 0.000 description 3
- 206010021639 Incontinence Diseases 0.000 description 3
- 208000009722 Overactive Urinary Bladder Diseases 0.000 description 3
- 208000005400 Synovial Cyst Diseases 0.000 description 3
- 206010046543 Urinary incontinence Diseases 0.000 description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 208000020629 overactive bladder Diseases 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000003071 parasitic effect Effects 0.000 description 3
- 210000002254 renal artery Anatomy 0.000 description 3
- 210000005070 sphincter Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002889 sympathetic effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 208000014094 Dystonic disease Diseases 0.000 description 2
- 208000034347 Faecal incontinence Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 206010008129 cerebral palsy Diseases 0.000 description 2
- 210000004889 cervical nerve Anatomy 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000002638 denervation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000010118 dystonia Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000002567 electromyography Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 201000006517 essential tremor Diseases 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000003872 feeding technique Methods 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000003698 laser cutting Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000000008 neuroelectric effect Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000012811 non-conductive material Substances 0.000 description 2
- 229960002748 norepinephrine Drugs 0.000 description 2
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 210000003903 pelvic floor Anatomy 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 210000003105 phrenic nerve Anatomy 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000008660 renal denervation Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 238000010897 surface acoustic wave method Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000002820 sympathetic nervous system Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010064687 Device related infection Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241001522296 Erithacus rubecula Species 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 229910000575 Ir alloy Inorganic materials 0.000 description 1
- 102000003752 Lipocalin 1 Human genes 0.000 description 1
- 108010057281 Lipocalin 1 Proteins 0.000 description 1
- 206010027566 Micturition urgency Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000004983 Phantom Limb Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000000697 Vocal Cord Dysfunction Diseases 0.000 description 1
- 208000013154 Vocal cord disease Diseases 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000002187 accessory nerve Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 210000001326 carotid sinus Anatomy 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000003029 clitoris Anatomy 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000109 continuous material Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000005226 corpus cavernosum Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 210000001983 hard palate Anatomy 0.000 description 1
- 201000000615 hard palate cancer Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 210000000194 hypogastric plexus Anatomy 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 210000003090 iliac artery Anatomy 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002847 impedance measurement Methods 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011900 installation process Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000001937 intercostal nerve Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000002988 lumbosacral plexus Anatomy 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 210000000337 motor cortex Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000003227 neuromodulating effect Effects 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 210000002416 recurrent laryngeal nerve Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 210000005227 renal system Anatomy 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 210000000954 sacrococcygeal region Anatomy 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 210000002466 splanchnic nerve Anatomy 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000004686 stellate ganglion Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000002222 superior cervical ganglion Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000001849 von ebner gland Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
- A61N1/37229—Shape or location of the implanted or external antenna
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0558—Anchoring or fixation means therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36125—Details of circuitry or electric components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37205—Microstimulators, e.g. implantable through a cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/378—Electrical supply
- A61N1/3787—Electrical supply from an external energy source
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B5/00—Near-field transmission systems, e.g. inductive or capacitive transmission systems
- H04B5/70—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes
- H04B5/79—Near-field transmission systems, e.g. inductive or capacitive transmission systems specially adapted for specific purposes for data transfer in combination with power transfer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/11—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis
- A61B17/1128—Surgical instruments, devices or methods, e.g. tourniquets for performing anastomosis; Buttons for anastomosis of nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B18/0206—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques ultrasonic, e.g. for destroying tissue or enhancing freezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B18/0218—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
- A61B2018/046—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; determining position of probes within or on the body of the patient
- A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
- A61B5/067—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe using accelerometers or gyroscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/025—Digital circuitry features of electrotherapy devices, e.g. memory, clocks, processors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0464—Specially adapted for promoting tissue growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0556—Cuff electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36002—Cancer treatment, e.g. tumour
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36057—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for stimulating afferent nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36071—Pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36107—Sexual dysfunction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/3611—Respiration control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
- A61N1/36117—Cardiac control, e.g. by vagal stimulation for treating hypertension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36121—Production of neurotransmitters; Modulation of genes expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3752—Details of casing-lead connections
- A61N1/3754—Feedthroughs
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J2310/00—The network for supplying or distributing electric power characterised by its spatial reach or by the load
- H02J2310/10—The network having a local or delimited stationary reach
- H02J2310/20—The network being internal to a load
- H02J2310/23—The load being a medical device, a medical implant, or a life supporting device
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J50/00—Circuit arrangements or systems for wireless supply or distribution of electric power
- H02J50/10—Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling
- H02J50/12—Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling of the resonant type
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Electromagnetism (AREA)
- Acoustics & Sound (AREA)
- Pulmonology (AREA)
- Signal Processing (AREA)
- Electrotherapy Devices (AREA)
- External Artificial Organs (AREA)
Description
本願は、以下の米国仮特許出願、2017年1月30日に出願され、「Circuitry Housing Assembly」と題する米国仮特許出願第62/452,052号、2017年5月25日に出願され、「Injectable Nerve-wrapping Electrode」と題する米国仮特許出願第62/511,075号、2017年6月5日に出願され、「Elongated Implantable Devices」と題された米国仮特許出願第62/515,220号、2017年5月30日に出願され、「Midfield Device Deployed in Arterial System」と題する米国仮特許出願第62/512,560号、2017年9月22日に出願され、「Midfield Device Deployable Inside Vasculature」と題する米国仮特許出願第62/562,023号、2017年12月14日に出願され、「Layered Midfield Transmitter with Dielectric Tuning」と題する米国仮特許出願第62/598,855号に対する優先権の利益を主張するものである。特定された米国仮出願それぞれのすべての内容は、参照により本明細書に組み込まれる。
I植込み型システムおよび装置
A.回路ハウジングアセンブリ
B.細長い植込み型アセンブリ
C.注入および/または神経ラッピング植込み式アセンブリ
D.血管の展開
II.層状のミッドフィールド送信機システムおよび装置
III.関連するコンピュータハードウェアおよび/またはアーキテクチャの実施形態
Claims (19)
- カニューレを使用して患者の体内に植込むように構成された細長い構造を含む植込み型システムであって、
その長手方向に沿って順に、近位部分、第1の可撓性部分、中央部分、第2の可撓性部分、および遠位部分を含む細長い回路基板アセンブリ、ならびに
前記細長い回路基板アセンブリを囲むように構成された気密筐体であり、
前記気密筐体の第1の側を覆う第1のエンドキャップであって、前記気密筐体の内側の前記細長い回路基板アセンブリの前記近位部分の導体に連結されるとともに前記気密筐体の外側の回路に連結された導電性の第1のフィードスルーを有する第1のエンドキャップ、および
前記気密筐体の、前記第1の側とは反対側の第2の側を覆う第2のエンドキャップであって、前記気密筐体の内側の前記細長い回路基板アセンブリの前記遠位部分の導体に連結されるとともに前記気密筐体の外側の電気刺激電極に連結された導電性の第2のフィードスルーを有する第2のエンドキャップ
を含む気密筐体
を備える、植込み型システム。 - 前記第1のフィードスルーに連結されたアンテナをさらに含み、前記第1の可撓性部分は前記第2の可撓性部分よりも短い長さを有する、請求項1に記載の植込み型システム。
- 前記第2のフィードスルーに連結された少なくとも1つの電気刺激電極をさらに備える、請求項1に記載の植込み型システム。
- 前記細長い構造に沿って異なる位置に設けられた複数の電気刺激電極をさらに備え、前記第2のエンドキャップが、前記細長い回路基板アセンブリの前記遠位部分のそれぞれの導体に連結された複数の導電性フィードスルーを含み、前記複数の電気刺激電極は、前記複数の導電性フィードスルーのそれぞれに連結されている、請求項1に記載の植込み型システム。
- 前記細長い回路基板アセンブリの前記近位部分、遠位部分、および中央部分は、前記細長い回路基板アセンブリの前記第1および第2の可撓性部分よりも剛性である、請求項1から4のいずれか一項に記載の植込み型システム。
- 前記細長い回路基板アセンブリの前記近位部分、遠位部分、および中央部分の剛性は、少なくとも部分的に、前記近位部分、遠位部分、および中央部分に設けられたはんだマスクに起因する、請求項5に記載の植込み型システム。
- 前記第1および第2のエンドキャップを前記筐体に連結する溶接またはろう付け材料をさらに備える、請求項1から4のいずれか一項に記載の植込み型システム。
- 前記近位部分または前記遠位部分が、前記回路基板を前記第1または第2のエンドキャップにそれぞれ連結するはんだバンプを備える、請求項1から4のいずれか一項に記載の植込み型システム。
- 前記筐体の内側の前記細長い回路基板アセンブリの一部に誘電性の充填材をさらに備える、請求項1から4のいずれか一項に記載の植込み型システム。
- 前記細長い回路基板の前記近位部分の前記導体は、前記第1のフィードスルーに連結されたビアを備える、請求項1から4のいずれか一項に記載の植込み型システム。
- カニューレを使用して患者の体内に植込むように構成された細長い構造を含む植込み型システムであって、
その長手方向に沿って順に、近位部分、第1の可撓性部分、および遠位部分を含む細長い回路基板アセンブリ、ならびに
前記細長い回路基板アセンブリを囲むように構成された気密筐体であり、
前記気密筐体の第1の側を覆う第1のエンドキャップであって、前記気密筐体の内側の前記細長い回路基板アセンブリの前記近位部分の導体に連結されるとともに前記気密筐体の外側の回路に連結された導電性の第1のフィードスルーを有する第1のエンドキャップ
を含む気密筐体
を備える、植込み型システム。 - 前記細長い回路基板アセンブリが、前記第1の可撓性部分と前記遠位部分との間に挿入された中央部分および第2の可撓性部分をさらに含む、請求項11に記載の植込み型システム。
- 前記第1のフィードスルーに連結されたアンテナをさらに含み、前記第1の可撓性部分は前記第2の可撓性部分よりも短い長さを有する、請求項12に記載の植込み型システム。
- 前記細長い回路基板アセンブリの前記遠位部分の導体に連結された導電性の第2のフィードスルーを有する第2のエンドキャップ、および
前記第2のフィードスルーに連結された少なくとも1つの電気刺激電極
をさらに備える、請求項11から13のいずれか一項に記載の植込み型システム。 - 前記細長い構造に沿って異なる位置に設けられた複数の電気刺激電極、および前記細長い回路基板アセンブリの前記遠位部分のそれぞれの導体に連結された複数の導電性フィードスルーを含む第2のエンドキャップをさらに備え、前記複数の電気刺激電極は、前記複数の導電性フィードスルーのそれぞれに連結されている、請求項11から13のいずれか一項に記載の植込み型システム。
- 前記細長い回路基板アセンブリの前記近位部分および前記遠位部分は、前記細長い回路基板アセンブリの前記第1の可撓性部分よりも剛性である、請求項11から13のいずれか一項に記載の植込み型システム。
- 前記細長い回路基板アセンブリの前記近位部分および前記遠位部分の剛性は、少なくとも部分的に、前記近位部分および前記遠位部分に設けられたはんだマスクに起因する、請求項16に記載の植込み型システム。
- 前記細長い回路基板の前記近位部分の前記導体は、前記第1のフィードスルーに連結されたビアを備える、請求項11から13のいずれか一項に記載の植込み型システム。
- 外部のミッドフィールド送信機から信号を無線で受信するように構成されたアンテナと、
体組織の誘電率と同等の誘電率を有する材料を含むアンテナハウジングと、
をさらに備え、
前記第1のエンドキャップは、前記気密筐体の内部から前記アンテナハウジングを分離する、
請求項1または11に記載の植込み型システム。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022003778A JP7301180B2 (ja) | 2017-01-30 | 2022-01-13 | ミッドフィールド送信機および受信機システム |
JP2023100501A JP2023120349A (ja) | 2017-01-30 | 2023-06-20 | ミッドフィールド送信機および受信機システム |
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762452052P | 2017-01-30 | 2017-01-30 | |
US62/452,052 | 2017-01-30 | ||
US201762511075P | 2017-05-25 | 2017-05-25 | |
US62/511,075 | 2017-05-25 | ||
US201762512560P | 2017-05-30 | 2017-05-30 | |
US62/512,560 | 2017-05-30 | ||
US201762515220P | 2017-06-05 | 2017-06-05 | |
US62/515,220 | 2017-06-05 | ||
US201762562023P | 2017-09-22 | 2017-09-22 | |
US62/562,023 | 2017-09-22 | ||
US201762598855P | 2017-12-14 | 2017-12-14 | |
US62/598,855 | 2017-12-14 | ||
PCT/US2018/016051 WO2018140983A1 (en) | 2017-01-30 | 2018-01-30 | Midfield transmitter and injectable midfield receiver |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022003778A Division JP7301180B2 (ja) | 2017-01-30 | 2022-01-13 | ミッドフィールド送信機および受信機システム |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2021511841A JP2021511841A (ja) | 2021-05-13 |
JP7050795B2 true JP7050795B2 (ja) | 2022-04-08 |
Family
ID=62978742
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019541245A Active JP7050795B2 (ja) | 2017-01-30 | 2018-01-30 | ミッドフィールド送信機および受信機システム |
JP2022003778A Active JP7301180B2 (ja) | 2017-01-30 | 2022-01-13 | ミッドフィールド送信機および受信機システム |
JP2023100501A Pending JP2023120349A (ja) | 2017-01-30 | 2023-06-20 | ミッドフィールド送信機および受信機システム |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022003778A Active JP7301180B2 (ja) | 2017-01-30 | 2022-01-13 | ミッドフィールド送信機および受信機システム |
JP2023100501A Pending JP2023120349A (ja) | 2017-01-30 | 2023-06-20 | ミッドフィールド送信機および受信機システム |
Country Status (7)
Country | Link |
---|---|
US (3) | US10485980B2 (ja) |
EP (1) | EP3573519A4 (ja) |
JP (3) | JP7050795B2 (ja) |
CN (1) | CN110461218A (ja) |
AU (3) | AU2018213427B2 (ja) |
CA (1) | CA3052093C (ja) |
WO (1) | WO2018140983A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11596794B2 (en) | 2017-12-14 | 2023-03-07 | NeuSpera Medical Inc. | Enhanced wireless communication and power transfer between external and implanted devices |
US11986662B2 (en) | 2017-01-30 | 2024-05-21 | NeuSpera Medical Inc. | Midfield transmitter systems |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2016342197B2 (en) | 2015-10-21 | 2020-10-22 | NeuSpera Medical Inc. | Devices, systems, and methods for stimulation therapy |
US10561842B2 (en) | 2017-12-14 | 2020-02-18 | NeuSpera Medical Inc. | Layered midfield transmitter with dielectric tuning |
EP3781255A4 (en) | 2018-04-19 | 2021-12-01 | Iota Biosciences, Inc. | IMPLANTS USING ULTRASOUND TRANSMISSION TO MODULATE THE ACTIVITY OF SPLEEN NERVES |
IL311077A (en) | 2018-08-29 | 2024-04-01 | Iota Biosciences Inc | Implantable closed-loop neuromodulation device, systems and methods for use |
KR102107025B1 (ko) * | 2018-09-14 | 2020-05-07 | 삼성전기주식회사 | 전자 소자 모듈 및 그 제조 방법 |
US11439832B2 (en) | 2019-01-09 | 2022-09-13 | Stimwave Technologies Incorporated | Implantable electronic devices |
US11065461B2 (en) | 2019-07-08 | 2021-07-20 | Bioness Inc. | Implantable power adapter |
AU2020322004A1 (en) * | 2019-07-30 | 2021-11-18 | Boston Scientific Scimed, Inc. | Electrosurgical tip |
WO2021067260A1 (en) * | 2019-10-01 | 2021-04-08 | Verily Life Sciences Llc | Separable high density connectors for implantable device |
EP4045133A4 (en) * | 2019-10-17 | 2023-11-22 | Iota Biosciences, Inc. | HELICAL NERVE SLEEVE AND RELATED IMPLANTABLE DEVICES |
US12017082B2 (en) * | 2019-11-13 | 2024-06-25 | Curonix Llc | Manufacturing implantable tissue stimulators |
FR3104448B1 (fr) * | 2019-12-12 | 2022-08-26 | Commissariat Energie Atomique | Dispositif d'illumination implantable dans un être vivant |
WO2021142546A1 (en) * | 2020-01-17 | 2021-07-22 | My01 Ip Holdings Inc. | Implantable sensor assembly including a sensor and a compliant structure |
US11918802B2 (en) | 2020-01-27 | 2024-03-05 | Medtronic, Inc. | Foramina-filling implantable medical lead |
TWI734371B (zh) * | 2020-02-07 | 2021-07-21 | 啓碁科技股份有限公司 | 天線結構 |
CN111407258A (zh) * | 2020-03-26 | 2020-07-14 | 苏州市东方电子仪器厂 | 多阳极食管心脏电生理导管技术 |
JP7409220B2 (ja) | 2020-05-12 | 2024-01-09 | 富士通株式会社 | 推定プログラム、モデル生成プログラム、推定方法、モデル生成方法、推定装置およびモデル生成装置 |
US11883176B2 (en) | 2020-05-29 | 2024-01-30 | The Research Foundation For The State University Of New York | Low-power wearable smart ECG patch with on-board analytics |
US11682924B2 (en) | 2020-06-08 | 2023-06-20 | Tc1 Llc | Systems and methods for wireless power resonators with core cavity |
US11911605B2 (en) * | 2021-03-05 | 2024-02-27 | Truerelief Llc | Method and apparatus for injury treatment |
WO2022212709A1 (en) * | 2021-04-01 | 2022-10-06 | Massachusetts Institute Of Technology | An electroceutical patch and catheter system and uses thereof |
CN113577576B (zh) * | 2021-09-02 | 2024-05-31 | 北京翌光医疗科技研究院有限公司 | 一种光医疗装置 |
WO2023076582A1 (en) * | 2021-10-29 | 2023-05-04 | Murata Manufacturing Co., Ltd. | Implantable device |
US20230211076A1 (en) * | 2021-12-30 | 2023-07-06 | Paul Weber | Compressible, minimally invasive implants and related systems and methods |
WO2024097409A2 (en) * | 2022-11-04 | 2024-05-10 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Context-aware circuit design for wearable biosymbiotic devices |
WO2024130401A1 (en) * | 2022-12-20 | 2024-06-27 | My01 Ip Holdings Inc. | Implantable sensor assembly including a sensor and a stiffened structure |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012508622A (ja) | 2008-11-13 | 2012-04-12 | プロテウス バイオメディカル インコーポレイテッド | 充電式刺激リード、システム、および方法 |
WO2015196164A2 (en) | 2014-06-21 | 2015-12-23 | Accelemed, Llc | Method and apparatus for neuromodulation treatments of pain and other conditions |
US20170001003A1 (en) | 2014-03-14 | 2017-01-05 | Nalu Medical, Inc. | Method and apparatus for versatile minimally invasive neuromodulators |
JP2018532501A (ja) | 2015-10-21 | 2018-11-08 | ニュースペラ メディカル インク | 刺激治療のための装置、システム、および方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4943809A (en) | 1985-06-25 | 1990-07-24 | Communications Satellite Corporation | Electromagnetically coupled microstrip antennas having feeding patches capacitively coupled to feedlines |
JPH0497604A (ja) | 1990-08-15 | 1992-03-30 | Hitachi Chem Co Ltd | スロット板を有するパッチアンテナ |
JPH04183003A (ja) | 1990-11-16 | 1992-06-30 | A T R Koudenpa Tsushin Kenkyusho:Kk | トリプレート型アンテナ |
JP3002315B2 (ja) | 1991-11-11 | 2000-01-24 | 勲 神田 | キャリヤ検査装置 |
JPH07162227A (ja) | 1993-12-07 | 1995-06-23 | Matsushita Electric Ind Co Ltd | 偏波共用アンテナシステム |
JP3808108B2 (ja) | 1994-05-02 | 2006-08-09 | 東ソー株式会社 | 圧電ポンプ |
ATE194733T1 (de) | 1996-04-03 | 2000-07-15 | Johan Granholm | Dualpolarisations-gruppenantenne mit sehr niedriger kreuzpolarisation und kleinen seitenkeulen |
FR2826209A1 (fr) | 2001-06-15 | 2002-12-20 | Thomson Licensing Sa | Dispositif pour la reception et/ou l'emission de signaux electromagnetiques a diversite de rayonnement |
US6707348B2 (en) | 2002-04-23 | 2004-03-16 | Xytrans, Inc. | Microstrip-to-waveguide power combiner for radio frequency power combining |
FR2858468A1 (fr) | 2003-07-30 | 2005-02-04 | Thomson Licensing Sa | Antenne planaire a diversite de rayonnement |
US20050177067A1 (en) * | 2004-02-11 | 2005-08-11 | Tracey Michael R. | System and method for urodynamic evaluation utilizing micro-electronic mechanical system |
US7191013B1 (en) | 2004-11-08 | 2007-03-13 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Hand held device for wireless powering and interrogation of biomems sensors and actuators |
US20070080864A1 (en) | 2005-10-11 | 2007-04-12 | M/A-Com, Inc. | Broadband proximity-coupled cavity backed patch antenna |
US9399130B2 (en) * | 2007-04-25 | 2016-07-26 | Medtronic, Inc. | Cannula configured to deliver test stimulation |
US20080287788A1 (en) * | 2007-05-14 | 2008-11-20 | Lifescience Solutions, Llc | Systems and methods for organ monitoring |
CN101912666B (zh) * | 2010-08-18 | 2014-12-03 | 中国科学院上海微系统与信息技术研究所 | 一种基于pdms的柔性植入式神经微电极及制作方法 |
US9132276B2 (en) | 2010-12-10 | 2015-09-15 | Cochlear Limited | Portable power charging of implantable medical devices |
EP2529790B1 (en) * | 2011-06-03 | 2017-09-20 | Greatbatch Ltd. | Feedthrough wire connector for use in a medical device |
EP2628504A1 (en) * | 2012-01-16 | 2013-08-21 | Greatbatch Ltd. | EMI filtered co-connected hermetic feedthrough, feedthrough capacitor and leadwire assembly for an active implantable medical device |
US8874206B2 (en) * | 2012-04-16 | 2014-10-28 | Boston Scientific Neuromodulation Corporation | Systems and methods for making and using electrical stimulation systems with improved RF compatibility |
EP3046621B1 (en) | 2013-09-16 | 2021-05-26 | The Board of Trustees of the Leland Stanford Junior University | Multi-element coupler for generation of electromagnetic energy |
EP3403692A1 (en) * | 2013-09-26 | 2018-11-21 | Oticon Medical A/S | A device implantable under skin |
US10118043B2 (en) | 2014-03-18 | 2018-11-06 | Cochlear Limited | Coil for signal transmission to implantable device |
EP4074273A1 (en) * | 2014-05-18 | 2022-10-19 | NeuSpera Medical Inc. | Midfield coupler |
US10811908B2 (en) | 2014-09-25 | 2020-10-20 | Supply, Inc. | System and method for wireless power reception |
EP3573519A4 (en) | 2017-01-30 | 2021-01-06 | NeuSpera Medical Inc. | MEDIUM FIELD TRANSMITTER AND INJECTABLE MEDIUM FIELD RECEIVER |
US10561842B2 (en) | 2017-12-14 | 2020-02-18 | NeuSpera Medical Inc. | Layered midfield transmitter with dielectric tuning |
US11596794B2 (en) | 2017-12-14 | 2023-03-07 | NeuSpera Medical Inc. | Enhanced wireless communication and power transfer between external and implanted devices |
-
2018
- 2018-01-30 EP EP18745034.1A patent/EP3573519A4/en active Pending
- 2018-01-30 JP JP2019541245A patent/JP7050795B2/ja active Active
- 2018-01-30 AU AU2018213427A patent/AU2018213427B2/en active Active
- 2018-01-30 CN CN201880021261.8A patent/CN110461218A/zh active Pending
- 2018-01-30 CA CA3052093A patent/CA3052093C/en active Active
- 2018-01-30 WO PCT/US2018/016051 patent/WO2018140983A1/en unknown
- 2018-06-11 US US16/004,894 patent/US10485980B2/en active Active
-
2019
- 2019-06-07 US US16/435,073 patent/US11198011B2/en active Active
-
2020
- 2020-06-04 AU AU2020203672A patent/AU2020203672B2/en active Active
-
2021
- 2021-10-20 AU AU2021254572A patent/AU2021254572B2/en active Active
- 2021-11-09 US US17/454,214 patent/US11986662B2/en active Active
-
2022
- 2022-01-13 JP JP2022003778A patent/JP7301180B2/ja active Active
-
2023
- 2023-06-20 JP JP2023100501A patent/JP2023120349A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012508622A (ja) | 2008-11-13 | 2012-04-12 | プロテウス バイオメディカル インコーポレイテッド | 充電式刺激リード、システム、および方法 |
US20170001003A1 (en) | 2014-03-14 | 2017-01-05 | Nalu Medical, Inc. | Method and apparatus for versatile minimally invasive neuromodulators |
WO2015196164A2 (en) | 2014-06-21 | 2015-12-23 | Accelemed, Llc | Method and apparatus for neuromodulation treatments of pain and other conditions |
JP2018532501A (ja) | 2015-10-21 | 2018-11-08 | ニュースペラ メディカル インク | 刺激治療のための装置、システム、および方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11986662B2 (en) | 2017-01-30 | 2024-05-21 | NeuSpera Medical Inc. | Midfield transmitter systems |
US11596794B2 (en) | 2017-12-14 | 2023-03-07 | NeuSpera Medical Inc. | Enhanced wireless communication and power transfer between external and implanted devices |
Also Published As
Publication number | Publication date |
---|---|
CA3052093A1 (en) | 2018-08-02 |
US20220062651A1 (en) | 2022-03-03 |
AU2021254572B2 (en) | 2023-10-12 |
AU2020203672B2 (en) | 2021-07-22 |
CN110461218A (zh) | 2019-11-15 |
EP3573519A1 (en) | 2019-12-04 |
US10485980B2 (en) | 2019-11-26 |
JP7301180B2 (ja) | 2023-06-30 |
CA3052093C (en) | 2023-10-31 |
AU2018213427A1 (en) | 2019-09-19 |
AU2018213427B2 (en) | 2020-03-05 |
AU2020203672A1 (en) | 2020-06-25 |
US20190290923A1 (en) | 2019-09-26 |
EP3573519A4 (en) | 2021-01-06 |
AU2021254572A1 (en) | 2021-11-18 |
JP2022046783A (ja) | 2022-03-23 |
JP2021511841A (ja) | 2021-05-13 |
US11198011B2 (en) | 2021-12-14 |
JP2023120349A (ja) | 2023-08-29 |
US11986662B2 (en) | 2024-05-21 |
WO2018140983A1 (en) | 2018-08-02 |
US20180289971A1 (en) | 2018-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7050795B2 (ja) | ミッドフィールド送信機および受信機システム | |
JP7359805B2 (ja) | 電磁エネルギー生成のための多素子カプラ | |
JP2023018156A (ja) | 刺激治療のための装置、システム、および方法 | |
US20210361940A1 (en) | Midfield power source for wireless implanted devices | |
US9333365B2 (en) | Antenna for an implantable medical device | |
US9610450B2 (en) | Antenna for an implantable medical device | |
JP7261814B2 (ja) | 無線の植込まれた装置用のミッドフィールド電源 | |
US20220314008A1 (en) | Wireless implantable device position validation in situ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191002 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191002 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200313 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20200507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200507 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201023 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210203 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210806 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210825 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220113 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220113 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220120 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220315 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220329 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7050795 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |